Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125774581 | 12577458 | 1 | I | 2006 | 20140416 | 20160720 | 20160720 | EXP | US-ACTELION-A-US2014-97860 | ACTELION | 57.00 | YR | A | F | Y | 0.00000 | 20160721 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125774581 | 12577458 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, UNK | Y | IP044P0101 | 21290 | 125 | MG | TABLET | |||||
| 125774581 | 12577458 | 2 | C | COUMADIN | WARFARIN SODIUM | 1 | 5 MG, UNK | U | 0 | 5 | MG | ||||||||
| 125774581 | 12577458 | 3 | C | COUMADIN | WARFARIN SODIUM | 1 | 7.5 MG, UNK | U | 0 | 7.5 | MG | ||||||||
| 125774581 | 12577458 | 4 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125774581 | 12577458 | 5 | C | MARIJUANA | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | U | 0 | |||||||||||
| 125774581 | 12577458 | 6 | C | POTASSIUM | POTASSIUM | 1 | 10 MG, BID | U | 0 | 10 | MG | BID | |||||||
| 125774581 | 12577458 | 7 | C | SILDENAFIL. | SILDENAFIL | 1 | 20 MG, BID | U | 0 | 20 | MG | BID | |||||||
| 125774581 | 12577458 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 80 MG, QAM | U | 0 | 80 | MG | QD | |||||||
| 125774581 | 12577458 | 9 | C | METOLAZONE. | METOLAZONE | 1 | 2.5 MG, UNK | U | 0 | 2.5 | MG | ||||||||
| 125774581 | 12577458 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 2 PUFF, QD | U | 0 | QD | |||||||||
| 125774581 | 12577458 | 11 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 2 PUFF, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125774581 | 12577458 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125774581 | 12577458 | HO |
| 125774581 | 12577458 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125774581 | 12577458 | Blister | |
| 125774581 | 12577458 | Chronic obstructive pulmonary disease | |
| 125774581 | 12577458 | Drug dependence | |
| 125774581 | 12577458 | Fluid retention | |
| 125774581 | 12577458 | Hepatic cirrhosis | |
| 125774581 | 12577458 | Hepatic enzyme increased | |
| 125774581 | 12577458 | Phlebitis | |
| 125774581 | 12577458 | Pulmonary arterial pressure increased | |
| 125774581 | 12577458 | Pyrexia | |
| 125774581 | 12577458 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125774581 | 12577458 | 1 | 2006 | 2015 | 0 | |
| 125774581 | 12577458 | 2 | 2006 | 0 | ||
| 125774581 | 12577458 | 7 | 2015 | 0 | ||
| 125774581 | 12577458 | 8 | 2006 | 0 | ||
| 125774581 | 12577458 | 10 | 2015 | 0 | ||
| 125774581 | 12577458 | 11 | 2014 | 0 |